ARTICLE | Company News
Activated Cell Therapy infectious diseases/aids, cancer news
September 8, 1997 7:00 AM UTC
The company changed its name to Dendreon Corp. to reflect its use of dendritic cells to develop therapies. Dendreon is in Phase I/II trials with dendritic cell therapy in prostate cancer. (Dendreon m...